Few & Far Between: How Biotech Gets Built

Chris O'Brien

English Health & Fitness Life Sciences Medicine Mental Health Science

Apple Podcasts Website RSS

Episodes 35

Avg. Duration 44m

Activity Highly Active

Apple Rating ★ 5.0 (15)

Since Dec 2023

Latest Episode May 2026

Outreach Signals

Has Video

Publishing Details

Schedule

Monthly

Format

Episodic

Consistency

60%

Hosting

feeds.castos.com

Contact & Outreach

About This Podcast

Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.

Explore Statistics

English Podcasts Report Health & Fitness Report Life Sciences Report Medicine Report Mental Health Report Science Report English Health & Fitness Report

Recent Episodes

S6E71 Episode 71: Chris O'Brien, Former ⁨Biorasi⁩ CEO and Current CEO of ⁨Rancho Biosciences

May 12, 2026 43m

Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences and Biorasi Board member - as they explore the origins and…

S6E69 Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School

Mar 17, 2026 1h 2m

Today on the Biorasi podcast, we look back on three years of AI innovation in healthcare and clinical trials - breaking new boundaries and a creating a new reality across all industries. Host Chris…

S6E68 Video Episode 68: Sinan Gölhan, CEO at GelTech Labs

Jan 27, 2026 44m

How do today’s CEOs and founders find the balance between planning and entrepreneurship? Check out the latest episode of the Biorasi Few & Far Between podcast - How Biotech Gets Built. Host Chris…

S6E67 Video Episode 67: Aoife Brennan, President and CEO of Climb Bio

Jan 07, 2026 1h 11m

Let's kick off 2026 with the first Biorasi podcast episode of the year! How do you get "Biotech Vision" to see the complete picture of your place in the industry? Find out in the latest episode of…

S5E66 Episode 66: Mark Abelson, Founder of Ora Clinical

Dec 16, 2025 43m

Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora Clinical and CRO…

S5E65 Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience

Nov 24, 2025 1h 6m

With biotech, is it the destination, the journey, or both? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Amit Etkin, Founder and CEO of…

S5E64 Video Episode 64 - Professor Justin Stebbing

Nov 11, 2025 47m

Will GLP-1's one day replace our morning coffee? Find out in a special video episode of the Few & Far Between podcast! Host Chris O'Brien welcomes friend of the show, Professor Justin Stebbing.…

S5E63 Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences

Oct 28, 2025 1h 1m

What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host, Chris O’Brien. Today, we welcome guest…

S5E62 Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology

Oct 22, 2025 44m

When is the right time for a biotech to bring in a Chief Marketing Officer/CMO? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Ken Suzuki,…

S5E61 Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics

Oct 01, 2025 45m

Why is a feather-light touch important in fighting infections? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Woody Bryan, President and CEO…

S5E60 Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Sep 17, 2025 42m

Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima Biotech, to the…

S5E59 Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Sep 03, 2025 43m

What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima…

S5E58 Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

Aug 14, 2025 44m

How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jerry McLaughlin, CEO…

S5E57 Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

Jul 22, 2025 44m

Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jim Brown, President and CEO of DURECT…

S5E56 Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

Jul 15, 2025 39m

How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael Tolentino, MD, Co-Founder and Head…

S5E55 Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

Jul 09, 2025 38m

How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this region. In our latest episode of the Biorasi Few…

S5E54 Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

May 28, 2025 45m

The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Michael Tolentino,…

S5E53 Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Apr 29, 2025 50m

How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan to the podcast. Tune in as we explore…

S5E52 Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

Apr 23, 2025 52m

How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far Between podcast! Host Chris O'Brien welcomes Joshua Kresh, Emily…

S5E51 Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

Apr 03, 2025 55m

How do you turn back the epigenetic clock for humans and their animal companions? Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of Rejuvenate Bio, to the podcast. Tune in as we take a deep…

Frequently Asked Questions

How many episodes does Few & Far Between: How Biotech Gets Built have?

Few & Far Between: How Biotech Gets Built has published 35 episodes since December 2023, covering topics in Health & Fitness, Life Sciences.

Is Few & Far Between: How Biotech Gets Built still active?

Few & Far Between: How Biotech Gets Built is currently highly active with new episodes monthly. Average episode length is 44m.

How do I contact Few & Far Between: How Biotech Gets Built for sponsorship or guest appearances?

Sign up on Grep.FM to access contact details for Few & Far Between: How Biotech Gets Built, including email and social media links.